Literature DB >> 18052865

Anti-retroviral therapy induced diabetes in a Nigerian.

Adamu G Bakari1, Fatima Sani-Bello, Mohammed S Shehu, Ahmed Mai, Ibrahim S Aliyu, Ibrahim I Lawal.   

Abstract

BACKGROUND: Anti-retroviral therapy (ART) using Highly Active Anti-retroviral Therapy (HAART) has led to considerable reduction in morbidity and mortality associated with human Immune deficiency virus (HIV) infection. This has led to increased life expectancy in HIV infected individuals on one hand, and side effects of chronic administration of these drugs on the other. One of such untoward effects is the association of anti-retroviral drugs especially the protease inhibitors (PI's) with metabolic derangements such as dyslipidaemia, lipodystrophy, insulin resistance and rarely Diabetes mellitus. Although there is extensive literature on this dysmetabolic syndrome in the Western World; there is to our knowledge no previous report from Nigeria.
OBJECTIVE: to report a case of diabetes mellitus following the initiation of anti-retroviral therapy.
METHODS: a case report of diabetes mellitus induced by anti-retroviral therapy in a 48 year old Nigerian male.
CONCLUSION: Awareness and high index of suspicion is required to identify the metabolic complications of ART.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18052865      PMCID: PMC2269721          DOI: 10.5555/afhs.2007.7.3.133

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  7 in total

Review 1.  Metabolic complications associated with antiretroviral therapy.

Authors:  R G Jain; E S Furfine; L Pedneault; A J White; J M Lenhard
Journal:  Antiviral Res       Date:  2001-09       Impact factor: 5.970

2.  The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

Authors:  H Murata; P W Hruz; M Mueckler
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

3.  Prevalence and incidence of diabetes in HIV-infected minority patients on protease inhibitors.

Authors:  Behrouz Salehian; Josephine Bilas; Mohsen Bazargan; Mohammad Abbasian
Journal:  J Natl Med Assoc       Date:  2005-08       Impact factor: 1.798

4.  The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance.

Authors:  M Caron; M Auclair; C Vigouroux; M Glorian; C Forest; J Capeau
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

5.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

Review 6.  AIDS-related lipodystrophy/insulin resistance syndrome.

Authors:  T Kino; M Mirani; S Alesci; G P Chrousos
Journal:  Horm Metab Res       Date:  2003-03       Impact factor: 2.936

7.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

  7 in total
  3 in total

1.  From HIV AIDS, TB to H. pylori and other infections in Africa.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2007-09       Impact factor: 0.927

2.  Access to antiretroviral therapy for adults and children with HIV infection in developing countries: Horizons studies, 2002-2008.

Authors:  Avina Sarna; Scott Kellerman
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

Review 3.  Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals.

Authors:  Angélica Saraí Jiménez-Osorio; Sinaí Jaen-Vega; Eduardo Fernández-Martínez; María Araceli Ortíz-Rodríguez; María Fernanda Martínez-Salazar; Reyna Cristina Jiménez-Sánchez; Olga Rocío Flores-Chávez; Esther Ramírez-Moreno; José Arias-Rico; Felipe Arteaga-García; Diego Estrada-Luna
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.